Cinacalcet attenuated bone loss via inhibiting parathyroid hormone-induced endothelial-to-adipocyte transition in chronic kidney disease rats

BACKGROUND: Recently, cinacalcet (CINA) has been shown to be effective for attenuating bone loss in the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), which might be associated with the reduction in serum parathyroid hormone (PTH) levels. However, th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Ni, Li-Hua, Tang, Ri-Ning, Yuan, Cheng, Song, Kai-Yun, Wang, Li-Ting, Zhang, Xiao-Liang, Lv, Lin-Li, Wang, Bin, Wu, Min, Tang, Tao-Tao, Li, Zuo-Lin, Yin, Di, Cao, Jing-Yuan, Wang, Xiao-Chen, Liu, Hong, Chen, Qiang, Liu, Bi-Cheng
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6694248/
https://ncbi.nlm.nih.gov/pubmed/31475182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.06.44
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados